Your browser doesn't support javascript.
loading
Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.
Lee, Jennifer J Y; Feldman, Brian M; McCrindle, Brian W; Li, Ping; Yeung, Rae Sm; Widdifield, Jessica.
Afiliación
  • Lee JJY; The Hospital for Sick Children (SickKids), Toronto, ON, Canada. Jennifer.lee@sickkids.ca.
  • Feldman BM; ICES, Toronto, ON, Canada. Jennifer.lee@sickkids.ca.
  • McCrindle BW; University of Toronto, Toronto, ON, Canada. Jennifer.lee@sickkids.ca.
  • Li P; The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
  • Yeung RS; University of Toronto, Toronto, ON, Canada.
  • Widdifield J; Institute of Health Policy, Management, & Evaluation, University of Toronto, Toronto, ON, Canada.
Pediatr Res ; 93(5): 1439-1446, 2023 04.
Article en En | MEDLINE | ID: mdl-36002584
BACKGROUND: This study evaluated the risk of hypertension, major adverse cardiac events (MACE), and all-cause mortality in Kawasaki disease (KD) patients up to young adulthood. METHODS: An inception cohort of 1169 KD patients between 1991 and 2008 from a tertiary-level hospital in Ontario, Canada was linked with health administrative data to ascertain outcomes up to 28 years of follow-up. Their risk was compared with 11,690 matched population comparators. The primary outcome was hypertension and secondary outcomes were MACE and death. RESULTS: After a median follow-up of 20 years [IQR: 8.3], the cumulative incidence of hypertension and MACE in the KD group was 3.8% (95% CI: 2.5-5.5) and 1.2% (95% CI: 0.6-2.4%), respectively. The overall survival probability in the KD group was 98.6% (95% CI: 97.2-99.3%). Relative to comparators, KD patients were at an increased risk for hypertension [aHR: 2.2 (95% CI: 1.5-3.4)], death [aHR: 2.5 (95% CI: 1.3-5.0)], and MACE [aHR: 10.7 (95% CI: 6.4-17.9)]. For hypertension and MACE, the aHR was the highest following diagnosis and then the excess risk diminished after 16 and 13 years of follow-up, respectively. MACE occurred largely in KD patients with coronary aneurysms [cumulative incidence: 12.8%]. CONCLUSIONS: KD patients demonstrated a reassuring cardiac prognosis up to young adulthood with low events and excellent survival. KD patients were at increased risk for hypertension, but this excess risk occurred early and declined with time. IMPACT: With the current standard of care, KD patients demonstrated favorable cardiac prognosis, with low events of hypertension, MACE, and excellent survival. Hypertension and MACE risk appear to be highest around the time of KD diagnosis. MACE occurred primarily in KD patients with coronary aneurysms. Our findings are reassuring to KD patients, families, and their providers. Our study demonstrated an association between KD exposure and hypertension. This association is relatively novel. Previous studies have remained conflicting if KD contributes to long-term atherosclerotic risk.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aneurisma Coronario / Hipertensión / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Pediatr Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aneurisma Coronario / Hipertensión / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Pediatr Res Año: 2023 Tipo del documento: Article